Olivier Bylicki
-
- Lung Cancer Treatments and Mutations 30
- Lung Cancer Diagnosis and Treatment 19
- Occupational and environmental lung diseases 9
- Pleural and Pulmonary Diseases 8
- Tracheal and airway disorders 5
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- C. ChouaïdFlorian GuisierN. PaleironMargarita MajemE. EigendorffMoïshe LibermanAyman SamkariTerufumi Kato
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Olivier Bylicki
71 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 1.0k
- Oncology 850
- Critical Care and Intensive Care Medicine 52
- Cancer Research 150
- Radiology, Nuclear Medicine and Imaging 124
Countries citing papers authored by Olivier Bylicki
This map shows the geographic impact of Olivier Bylicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Bylicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Bylicki more than expected).
Fields of papers citing papers by Olivier Bylicki
This network shows the impact of papers produced by Olivier Bylicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Bylicki. The network helps show where Olivier Bylicki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier Bylicki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 215 | |
| 15 | 2017 | 12 | |
| 16 | 2017 | 1 | |
| 17 | 2014 | 10 | |
| 18 | 2013 | 51 | |
| 19 | 2012 | 1 | |
| 20 | 2012 | 7 |
About Olivier Bylicki
Olivier Bylicki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Microbiology, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (13 papers), Occupational and environmental lung diseases (9 papers), Pleural and Pulmonary Diseases (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Tracheal and airway disorders (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Oncology (850 citations) and Critical Care and Intensive Care Medicine (52 citations). Olivier Bylicki has collaborated with scholars based in France, United States and Canada. Frequent co-authors include C. Chouaïd, Florian Guisier, N. Paleiron, Margarita Majem, E. Eigendorff, Moïshe Liberman, Ayman Samkari, Terufumi Kato, Heather A. Wakelee and Gastón Lucas Martinengo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.